CAMBRIDGE, MA – Seres Therapeutics, Inc. (NASDAQ:MCRB), a biopharmaceutical company specializing in pharmaceutical preparations, announced on Monday the appointment of Dr. Hans-Juergen Woerle as a new ...
C AMBRIDGE, Mass. - Seres Therapeutics, Inc. (NASDAQ:MCRB), a clinical-stage biotherapeutic company with a market capitalization of $133 million, announced today that it has received a $50 million ...
CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 ...
Seres Therapeutics, Inc. announced the receipt of a $50 million installment payment from Nestlé Health Science related to the sale of its VOWST business, contributing to the company's financial ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
CAMBRIDGE, MA – Seres Therapeutics, Inc. (NASDAQ:MCRB), a biopharmaceutical company specializing in pharmaceutical preparations, announced on Monday the appointment of Dr. Hans-Juergen Woerle as ...
CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback